Escitalopram for frequent asthma attacks
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether the antidepressant escitalopram can reduce asthma attacks in people who have frequent, severe flare-ups despite using their regular inhalers. It may help if you have moderate to severe asthma and have had 3 or more attacks needing steroids in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe asthma that requires medium to high doses of inhaled steroids and a long-acting inhaler.
- You have had 3 or more severe asthma attacks in the past year that each needed at least 3 days of steroid pills or liquid.
- You are between 18 and 75 years old and speak English or Spanish.
- Your asthma has been stable for at least 4 weeks before joining, with no recent attacks or changes to your daily asthma medicines.
- You are not currently smoking, have not smoked heavily in the past, and do not have a current substance use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a long-term, low-dose antibiotic (azithromycin) to your usual asthma treatment can help improve control and reduce attacks. It is for people whose asthma is still not well controlled despite using a daily inhaler.
This study aims to improve care for people with asthma who are at higher risk of severe flare-ups. It may test new ways to manage asthma and help you avoid hospital visits.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.